Olachi Mezu-Ndubuisi, MD, OD (she/her/hers)

Associate Professor with Tenure
University of Rochester School of Medicine and Dentistry
Rochester, New York, United States

Presentation(s):

• Optimization of intravitreal Bevacizumab nanoparticles for the treatment of retinopathy of prematurity (ROP)

  Saturday, April 26, 2025
  1:00pm – 1:15pm HST

  Disclosure(s): I do not have any relevant financial / non-financial relationships with any proprietary interests.

• The role of Interleukin-4 receptor alpha in inflammation and angiogenesis in an in vivo mouse model of retinopathy of prematurity

  Saturday, April 26, 2025
  1:30pm – 1:45pm HST

  Disclosure(s): I do not have any relevant financial / non-financial relationships with any proprietary interests.